Filing Details
- Accession Number:
- 0001213900-23-020668
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-16 17:11:48
- Reporting Period:
- 2023-03-14
- Accepted Time:
- 2023-03-16 17:11:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1912582 | Feutune Light Acquisition Corp | FLFV | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1864956 | Lei Xu | I/C/O Feutune Light Acquisition Corp 48 Bridge Street, Building A Metuchen NJ 08840 | President And Chairwoman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class B Common Stock | Disposition | 2023-03-14 | 26,010 | $0.01 | 126,990 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Class B common stock will automatically convert into Class A common stock on one-for-one basis, subject to certain adjustments as provided in the amended and restated certificate of incorporation of Feutune Light Acquisition Corporation (the "Issuer") upon the consummation of an initial business combination
- Representing 26,010 shares of Class B Common Stock that Dr. Xu transferred to Feutune Light Sponsor LLC (the "Sponsor") pursuant to certain securities transfer agreement dated March 14, 2023 among Sponsor and certain initial stockholders of the Issuer
- Including (i) 153,000 shares if Class B Common Stock that Dr. Xu acquired from the Sponsor, pursuant to a securities transfer agreement dated June 15, 2022, among Sponsor and certain initial stockholders of the Issuer, and (ii) 23,970 shares of Class B Common Stock that Dr. Xu transferred to the Sponsor pursuant to certain securities transfer agreement dated March 14, 2023 among Sponsor and certain initial stockholders of the Issuer, as disclosed in footnote 2.